Arkolith/Insider Trading/IMUN/Form 4

Griffin Noreen

10% OwnerImmune Therapeutics, Inc. (IMUN) · full profile →Form 4 · filed Jun 4, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2021Other(J)0—$03K
May 28, 2021Other(J)0—$0429
May 28, 2021Other(J)0—$0704

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2021Other(J)0—$07K
May 28, 2021Other(J)0—$050K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-031071) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML